Form 8-K AKORN INC For: Apr 24
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Buy Akorn (AKRX) on Sell-Off, Guggenheim Says
April 27, 2015 1:03 PM EDTGuggenheim analyst Louise Chen is telling clients to Buy the weakness in Akorn (NASDAQ: AKRX) with shares down 20.9% after it announced that there will be additional financial restatements for '14. Chen notes this means the company's 10-K will need to be filed again.... More
Akorn (AKRX) Appoints Two New EVPs, One Corp. Controller
April 27, 2015 8:30 AM EDTAkorn (NASDAQ: AKRX) announced the following recent executive appointments for roles on the Akorn management team:
Jonathan Kafer, former Vice President, Account Management at Allergan, Inc., was appointed Executive Vice President, Sales and Marketing. In this newly-created role, Mr. Kafer will oversee all commercial functions for all of Akorn's business units. Mr. Kafer will also play an integral role in strategic market and product portfolio considerations. At Allergan, Mr. Kafer was responsible for all trade activity within Allergan's wholesale, retail specialty pharmacy, e-Solutions and managed market channels for... More